0001209191-14-041450.txt : 20140624 0001209191-14-041450.hdr.sgml : 20140624 20140613202907 ACCESSION NUMBER: 0001209191-14-041450 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20140613 FILED AS OF DATE: 20140613 DATE AS OF CHANGE: 20140613 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SPECTRUM PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000831547 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930979187 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11500 S. EASTERN AVE., SUITE 240 CITY: HENDERSON STATE: NV ZIP: 89052 BUSINESS PHONE: 702-835-6300 MAIL ADDRESS: STREET 1: 11500 S. EASTERN AVE., SUITE 240 CITY: HENDERSON STATE: NV ZIP: 89052 FORMER COMPANY: FORMER CONFORMED NAME: NEOTHERAPEUTICS INC DATE OF NAME CHANGE: 19960819 FORMER COMPANY: FORMER CONFORMED NAME: AMERICUS FUNDING CORP DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Krassner Stuart Mitchell CENTRAL INDEX KEY: 0001311636 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35006 FILM NUMBER: 14911406 MAIL ADDRESS: STREET 1: 157 TEHCNOLOGY DRIVE CITY: IRVINE STATE: CA ZIP: 92618 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2014-06-13 0 0000831547 SPECTRUM PHARMACEUTICALS INC SPPI 0001311636 Krassner Stuart Mitchell 11500 S. EASTERN AVENUE SUITE 240 HENDERSON NV 89052 1 0 0 0 Common Stock, $0.001 par value 2014-06-13 4 F 0 1250 8.42 D 18750 D Represents restricted shares withheld by Spectrum to satisfy the Reporting Person's tax withholding obligations. The shares have not been sold by the Reporting Person or by Spectrum. The shares have been cancelled by the transfer agent and returned to Spectrum's authorized and unissued share pool. /s/ Kurt A. Gustafson, attorney-in-fact for Stuart M. Krassner 2014-06-13 EX-24 2 attachment1.htm EX-24 DOCUMENT

POWER OF ATTORNEY



AUTHORIZATION

I hereby authorize Rajesh C. Shrotriya, Abraham N. Oler, Kurt A. Gustafson or
Joseph W. Turgeon,
acting singly, to sign and file on my behalf any and all forms required by the
Securities and Exchange
Commission pursuant to Section 16 of the Securities Exchange Act of 1934 (the
"Exchange Act") relating
to the reporting of beneficial ownership of equity securities of Spectrum
Pharmaceuticals, Inc., a
Delaware corporation (the "Company"), and of changes in such beneficial
ownership, together with any
and all amendments thereto.  This authorization shall be effective on and after
the date set forth below
and shall continue in effect until I am no longer required to file such forms,
unless earlier revoked
by me in writing.

I acknowledge that the persons authorized hereunder are not assuming, nor is the
Company assuming,
any of my responsibilities to comply with Section 16 of the Exchange Act.

Dated as of this 13th day of June, 2014.



						/s/ Stuart M. Krassner
						Stuart M. Krassner